Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Thursday, December 09, 2021
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis (...
read more
Wednesday, December 08, 2021
Pfizer Inc. and BioNTech SE announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 ...
read more
Wednesday, December 08, 2021
Valneva SE announced the signing of an advance purchase agreement with the Kingdom of Bahrain for the supply of one million doses of the Company’s inactivated COVID-19 vaccine candidate VLA2001. This ...
read more
Tuesday, December 07, 2021
Sosei Group Corporation announced it has received grant funding from Wellcome, through the COVID-19 Therapeutics Accelerator.
read more
Tuesday, December 07, 2021
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline announced positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of ...
read more
Monday, December 06, 2021
Merck has entered into a Supply Agreement with the Government of Canada for up to 1 million patient courses of molnupiravir, its investigational oral antiviral medicine for the treatment of COVID-19. ...
read more
Thursday, December 02, 2021
ARCA biopharma, Inc. announced that enrollment has been completed in ASPEN-COVID-19, the Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for patients hospitalized with COVID-19. ...
read more
Wednesday, December 01, 2021
Biopharmaceutical companies obtain research and development expertise to progress pipeline development projects. While these companies also have internal manufacturing expertise, it is often not to ...
read more
Wednesday, December 01, 2021
COVID-19 vaccines have been developed in response to the worldwide pandemic at an incredible rate. By November 9, 2021, 7.3 billion COVID-19 vaccine doses had been delivered worldwide, with approx. 30...
read more
Wednesday, December 01, 2021
“Life should not be a journey to the grave with the intention of arriving safely in a pretty and well-preserved body, but rather to skid in broadside in a cloud of smoke, thoroughly used up, totally ...
read more
Wednesday, December 01, 2021
For many years pharmaceutical companies have relied upon chemical methods to inactivate microorganisms and viruses present in their
facilities. Over these same years we have found issues with the ...
read more
Wednesday, December 01, 2021
Merck and Ridgeback Biotherapeutics provided the following statement at the conclusion of the FDA Antimicrobial Drugs Advisory Committee (AMDAC) regarding the Emergency Use Authorization (EUA) ...
read more
Wednesday, December 01, 2021
Vaxart, Inc. has entered into an agreement with Kindred Bioscience, Inc. for the purchase of KindredBio’s manufacturing equipment and sublease of its GMP (Good Manufacturing Practices) manufacturing ...
read more
Wednesday, November 24, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.
read more
Monday, November 22, 2021
Pfizer Inc. and BioNTech SE announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals 12 through 15 years of age.
read more